Euronext

Photo

Syensqo Launched on Euronext

Yesterday, Syensqo announced the listing of its shares on Euronext Brussels and Euronext Paris. After completing the spin-off from Solvay, the listing marks a historical milestone as the company embarks on an innovation-driven journey.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.